Watermark
  Back to Search Results

BGB-A317-30813-101

Terminated

A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-30813-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05904496

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2023

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20233404

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary